Furberg CD - Search Results

1

Rationale and design for the Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). ALLHAT Research Group.

Davis BR, Cutler JA, Gordon DJ, Furberg CD, Wright JT Jr, Cushman WC, Grimm RH, LaRosa J, Whelton PK, Perry HM, Alderman MH, Ford CE, Oparil S, Francis C, Proschan M, Pressel S, Black HR, Hawkins CM. Davis BR, et al. Among authors: furberg cd. Am J Hypertens. 1996 Apr;9(4 Pt 1):342-60. doi: 10.1016/0895-7061(96)00037-4. Am J Hypertens. 1996. PMID: 8722437 Clinical Trial.

2

Operational aspects of terminating the doxazosin arm of The Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).

Pressel SL, Davis BR, Wright JT, Geraci TS, Kingry C, Ford CE, Piller LB, Bettencourt J, Kimmel B, Lusk C, Parks H, Simpson LM, Nwachuku C, Furberg CD; ALLHAT Collaborative Research Group. Pressel SL, et al. Among authors: furberg cd. Control Clin Trials. 2001 Feb;22(1):29-41. doi: 10.1016/s0197-2456(00)00109-4. Control Clin Trials. 2001. PMID: 11165421 Clinical Trial.

3

Clinical Implications of Recent Findings from the Antihypertensive and Lipid-Lowering Treatment To Prevent Heart Attack Trial (ALLHAT) and Other Studies of Hypertension.

Furberg CD, Psaty BM, Pahor M, Alderman MH. Furberg CD, et al. Ann Intern Med. 2001 Dec 18;135(12):1074-8. doi: 10.7326/0003-4819-135-12-200112180-00011. Ann Intern Med. 2001. PMID: 11747386 Review.

4

The Systolic Hypertension in the Elderly Program (SHEP): an intervention trial on isolated systolic hypertension. SHEP Cooperative Research Group.

Probstfield JL, Applegate WB, Borhani NO, Curb JD, Cutler JA, Davis BR, Furberg CD, Hawkins CM, Lakatos E, Page LB, et al. Probstfield JL, et al. Among authors: furberg cd. Clin Exp Hypertens A. 1989;11(5-6):973-89. doi: 10.3109/10641968909035386. Clin Exp Hypertens A. 1989. PMID: 2676266 Clinical Trial.

5

Drug treatment trials in hypertension: a review.

Cutler JA, Furberg CD. Cutler JA, et al. Among authors: furberg cd. Prev Med. 1985 Jul;14(4):499-518. doi: 10.1016/0091-7435(85)90010-6. Prev Med. 1985. PMID: 3906629 Clinical Trial.

6

The National Heart, Lung, and Blood Institute Workshop on antihypertensive drug treatment. The benefits, costs, and choices. Implications for research.

Furberg CD, Cutler JA. Furberg CD, et al. Hypertension. 1989 May;13(5 Suppl):I171-2. doi: 10.1161/01.hyp.13.5_suppl.i171. Hypertension. 1989. PMID: 2490823

7

Controlled clinical trials of drug treatment for hypertension. A review.

Cutler JA, MacMahon SW, Furberg CD. Cutler JA, et al. Among authors: furberg cd. Hypertension. 1989 May;13(5 Suppl):I36-44. doi: 10.1161/01.hyp.13.5_suppl.i36. Hypertension. 1989. PMID: 2490827 Review.

8

Diuretic agents versus beta-blockers. Comparison of effects on mortality, stroke, and coronary events.

Furberg CD, Cutler JA. Furberg CD, et al. Hypertension. 1989 May;13(5 Suppl):I57-61. doi: 10.1161/01.hyp.13.5_suppl.i57. Hypertension. 1989. PMID: 2577460 Clinical Trial.

9

Survival analysis of adverse effects data in the Beta-Blocker Heart Attack Trial.

Davis BR, Furberg CD, Williams CB. Davis BR, et al. Among authors: furberg cd. Clin Pharmacol Ther. 1987 Jun;41(6):611-5. doi: 10.1038/clpt.1987.83. Clin Pharmacol Ther. 1987. PMID: 3555942 Clinical Trial.

10

Trends in pharmacologic management of hypertension in the United States.

Manolio TA, Cutler JA, Furberg CD, Psaty BM, Whelton PK, Applegate WB. Manolio TA, et al. Among authors: furberg cd. Arch Intern Med. 1995 Apr 24;155(8):829-37. Arch Intern Med. 1995. PMID: 7717791 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

411 results

Search Page